(Q39372438)

English

Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

multicenter clinical trial

0 references

0 references

pain management

0 references

author name string

G W Hanks

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

M Nugent

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

C M B Higgs

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

M A Busch

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

OTFC Multicentre Study Group

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Palliative Medicine

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

698-704

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Breakthrough pain: definition, prevalence and characteristics

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM966OA

21 January 2018

ABC of palliative care. Difficult pain problems

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM966OA

21 January 2018

Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM966OA

21 January 2018

Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM966OA

21 January 2018

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM966OA

21 January 2018

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM966OA

21 January 2018

A comparison of observational studies and randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM966OA

21 January 2018

Identifiers

10.1191/0269216304PM966OA

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39372438&oldid=1823323473"